Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

11 passages

narrativemksap-19· p.104

Bibliography Stroke Nikooie R, Neufeld KJ, Oh ES, et al. Antipsychotics for Treating Delirium in Hospitalized Adults: A Systematic Review. Ann Intern Med. 2019;171:485- D’Anci KE, UhIS, Oristaglio J, et al. Treatments for Poststroke Motor Deficits 495. [PMID: 31476770] doi:10.7326/M19-1860 and Mood Disorders: A Systematic Review for the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Stroke Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update sum- Rehabilitation. Ann Intern Med. 2019;171:906-915. [PMID: 31739315] mary: Mild cognitive impairment: Report of the Guideline Development, doi:10.7326/M19-2414 Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90:126-135. [PMID: 29282327] Gross BA, Jankowitz BT, Friedlander RM. Cerebral intraparenchymal hemor- doi:10.1212/ WNL.0000000000004826 rhage: a review. JAMA. 2019 Apr 2; 321(13):1295-303. [PMID: 30938800] doi: 10.1001/jama.2019.2413. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart 2011;134:2456-77. [PMID: 21810890] doi:10.1093/brain/awr179 Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontane- Reams N, Eckner JT, Almeida AA, et al. A Clinical Approach to the Diagnosis of ous intracerebral hemorrhage: a guideline for healthcare professionals from Traumatic Encephalopathy Syndrome: A Review. JAMA Neurol. 2016;73:743- the American Heart Association/American Stroke Association. Stroke. 2015 9. [PMID: 27111824] Jul;46(7):2032-60. [PMID: 26022637] doi:10.1161/STR.0000000000000069. Ritter A, Pillai J. Treatment of vascular cognitive impairment. Curr Treat Johnston KC, Bruno A, Pauls Q, et al; Neurological Emergencies Treatment Options Neurol. 2015 Aug;17(8):367. [PMID: 26094078] doi:10.1007/s11940- Trials Network and the SHINE Trial Investigators. Intensive vs standard 015-0367-0. treatment of hyperglycemia and functional outcome in patients with acute Stréhle A, Schmidt DK, Schultz F, et al. Drug and Exercise Treatment of ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019 Jul Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review 23;322(4):326-35. [PMID: 31334795] doi: 10.1001/jama.2019.9346. and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Kuijpers T, Spencer FA, Siemieniuk RAC, et al. Patent foramen ovale closure, Am J Geriatr Psychiatry. 2015;23:1234-1249. [PMID: 26601726] doi:10.1016/j. antiplatelet therapy or anticoagulation therapy alone for management of jagp.2015.07.007 cryptogenic stroke? A clinical practice guideline. BMJ. 2018:362:K2515. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening [PMID: 30045912] doi:10.1136/bmj.k2515 for cognitive impairment in older adults: US Preventive Services Task Force Lawton MT, Vates GE. Subarachnoid Hemorrhage. N Engl J Med. 2017;377:257- recommendation statement. JAMA. 2020;323(8):757-63. [PMID: 32096858] 266. [PMID: 28723321] doi:10.1056/NEJMcp1605827 doi:10.1001/jama.2020.0435

narrativemksap-19· p.104

Stroke Nikooie R, Neufeld KJ, Oh ES, et al. Antipsychotics for Treating Delirium in Hospitalized Adults: A Systematic Review. Ann Intern Med. 2019;171:485- D’Anci KE, UhIS, Oristaglio J, et al. Treatments for Poststroke Motor Deficits 495. [PMID: 31476770] doi:10.7326/M19-1860 and Mood Disorders: A Systematic Review for the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Stroke Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update sum- Rehabilitation. Ann Intern Med. 2019;171:906-915. [PMID: 31739315] mary: Mild cognitive impairment: Report of the Guideline Development, doi:10.7326/M19-2414 Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90:126-135. [PMID: 29282327] Gross BA, Jankowitz BT, Friedlander RM. Cerebral intraparenchymal hemor- doi:10.1212/ WNL.0000000000004826 rhage: a review. JAMA. 2019 Apr 2; 321(13):1295-303. [PMID: 30938800] doi: 10.1001/jama.2019.2413. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart 2011;134:2456-77. [PMID: 21810890] doi:10.1093/brain/awr179 Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontane- Reams N, Eckner JT, Almeida AA, et al. A Clinical Approach to the Diagnosis of ous intracerebral hemorrhage: a guideline for healthcare professionals from Traumatic Encephalopathy Syndrome: A Review. JAMA Neurol. 2016;73:743- the American Heart Association/American Stroke Association. Stroke. 2015 9. [PMID: 27111824] Jul;46(7):2032-60. [PMID: 26022637] doi:10.1161/STR.0000000000000069. Ritter A, Pillai J. Treatment of vascular cognitive impairment. Curr Treat Johnston KC, Bruno A, Pauls Q, et al; Neurological Emergencies Treatment Options Neurol. 2015 Aug;17(8):367. [PMID: 26094078] doi:10.1007/s11940- Trials Network and the SHINE Trial Investigators. Intensive vs standard 015-0367-0. treatment of hyperglycemia and functional outcome in patients with acute Stréhle A, Schmidt DK, Schultz F, et al. Drug and Exercise Treatment of ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019 Jul Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review 23;322(4):326-35. [PMID: 31334795] doi: 10.1001/jama.2019.9346. and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Kuijpers T, Spencer FA, Siemieniuk RAC, et al. Patent foramen ovale closure, Am J Geriatr Psychiatry. 2015;23:1234-1249. [PMID: 26601726] doi:10.1016/j. antiplatelet therapy or anticoagulation therapy alone for management of jagp.2015.07.007 cryptogenic stroke? A clinical practice guideline. BMJ. 2018:362:K2515. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening [PMID: 30045912] doi:10.1136/bmj.k2515 for cognitive impairment in older adults: US Preventive Services Task Force Lawton MT, Vates GE. Subarachnoid Hemorrhage. N Engl J Med. 2017;377:257- recommendation statement. JAMA. 2020;323(8):757-63. [PMID: 32096858] 266. [PMID: 28723321] doi:10.1056/NEJMcp1605827 doi:10.1001/jama.2020.0435 Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Watt JA, Goodarzi Z, Veroniki AA, et al. Comparative Efficacy of Interventions Management of Patients With Acute Ischemic Stroke: 2019 Update to the for Aggressive and Agitated Behaviors in Dementia: A Systematic Review 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A and Network Meta-analysis. Ann Intern Med. 2019;171:633-642. [PMID: Guideline for Healthcare Professionals From the American Heart 31610547] doi:10.7326/M19-0993 Association/American Stroke Association [Editorial]. Stroke. 2019; World Health Organization. Risk reduction of cognitive decline and dementia 50:e344-e418. [PMID: 31662037] doi:10.1161/STR.0000000000000211 [Internet]. WHO Guidelines. 2019. Available at: https://www.who.int/men- Prasad K, Siemieniuk R, Hao Q, et al. Dual antiplatelet therapy with aspirin tal_health/neurology/dementia/guidelines_risk_reduction/en. and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. [PMID: Movement Disorders 30563885] doi:10.1136/bmj.k5130 Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nat Rev Dis Primers. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medi- 2018;4(1):25. [PMID: 30237473] doi:10.1038/s41572-018-0023-6. cal patients: a clinical practice guideline. BMJ. 2018;363:k4169. [PMID: Feinstein E, Walker R. An update on the treatment of chorea. Curr Treat 30355567] doi:10.1136/bmj.k4169 Options Neurol. 2018 Sep 25;20(10):44. [PMID: 30255459] doi: 10.1007/ Thompson BG, Brown RD Jr, Amin-Hanjani S, et al; American Heart s11940-018-0529-y. Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Haubenberger D, Hallett M. Essential tremor. N Engl J Med. 2018 May and Council on Epidemiology and Prevention. Guidelines for the 10;378(19):1802-10. [PMID: 29742376] doi: 10.1056/NEJMcp1707928. Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Homayoun H. Parkinson disease. Ann Intern Med. 2018 Sep 4;169(5):ITC33- Association/American Stroke Association. Stroke. 2015;46:2368-400. 48. [PMID: 30178019] doi: 10.7326/AITC201809040. [PMID: 26089327] doi:10.1161/STR.0000000000000070 Malek N, Baker MR. Common toxidromes in movement disorder neurology. Yaghi S, Willey JZ, Cucchiara B, et al; American Heart Association Stroke Postgrad Med J. 2017 Jun;93(1100):326-32. [PMID: 28546460] doi: 10.1136/

narrativemksap-19· p.104

Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Watt JA, Goodarzi Z, Veroniki AA, et al. Comparative Efficacy of Interventions Management of Patients With Acute Ischemic Stroke: 2019 Update to the for Aggressive and Agitated Behaviors in Dementia: A Systematic Review 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A and Network Meta-analysis. Ann Intern Med. 2019;171:633-642. [PMID: Guideline for Healthcare Professionals From the American Heart 31610547] doi:10.7326/M19-0993 Association/American Stroke Association [Editorial]. Stroke. 2019; World Health Organization. Risk reduction of cognitive decline and dementia 50:e344-e418. [PMID: 31662037] doi:10.1161/STR.0000000000000211 [Internet]. WHO Guidelines. 2019. Available at: https://www.who.int/men- Prasad K, Siemieniuk R, Hao Q, et al. Dual antiplatelet therapy with aspirin tal_health/neurology/dementia/guidelines_risk_reduction/en. and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. [PMID: Movement Disorders 30563885] doi:10.1136/bmj.k5130 Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nat Rev Dis Primers. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medi- 2018;4(1):25. [PMID: 30237473] doi:10.1038/s41572-018-0023-6. cal patients: a clinical practice guideline. BMJ. 2018;363:k4169. [PMID: Feinstein E, Walker R. An update on the treatment of chorea. Curr Treat 30355567] doi:10.1136/bmj.k4169 Options Neurol. 2018 Sep 25;20(10):44. [PMID: 30255459] doi: 10.1007/ Thompson BG, Brown RD Jr, Amin-Hanjani S, et al; American Heart s11940-018-0529-y. Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Haubenberger D, Hallett M. Essential tremor. N Engl J Med. 2018 May and Council on Epidemiology and Prevention. Guidelines for the 10;378(19):1802-10. [PMID: 29742376] doi: 10.1056/NEJMcp1707928. Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Homayoun H. Parkinson disease. Ann Intern Med. 2018 Sep 4;169(5):ITC33- Association/American Stroke Association. Stroke. 2015;46:2368-400. 48. [PMID: 30178019] doi: 10.7326/AITC201809040. [PMID: 26089327] doi:10.1161/STR.0000000000000070 Malek N, Baker MR. Common toxidromes in movement disorder neurology. Yaghi S, Willey JZ, Cucchiara B, et al; American Heart Association Stroke Postgrad Med J. 2017 Jun;93(1100):326-32. [PMID: 28546460] doi: 10.1136/ Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical postgradmedj-2016-134254. Cardiology; and Council on Quality of Care and Outcomes Research. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Treatment and Outcome of Hemorrhagic Transformation After Intravenous Parkinson’s disease. Mov Disord. 2015 Oct;30(12):1591-601. [PMID: Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare 26474316]. doi:10.1002/mds.26424. Professionals From the American Heart Association/American Stroke Pringsheim T, Okun MS, Miiller-Vahl K, et al. Practice guideline reeommenda- Association. Stroke. 2017:48:e343-e361. [PMID: 29097489] doi:10.1161/ tions summary: treatment of tics in people with Tourette syndrome and STR.0000000000000152 chronic tic disorders. Neurology. 2019 May 7;92(19):896-906. [PMID: Cognitive Impairment 31061208] doi: 10.1212/WNL.0000000000007466.

narrativemksap-19· p.104

Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical postgradmedj-2016-134254. Cardiology; and Council on Quality of Care and Outcomes Research. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Treatment and Outcome of Hemorrhagic Transformation After Intravenous Parkinson’s disease. Mov Disord. 2015 Oct;30(12):1591-601. [PMID: Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare 26474316]. doi:10.1002/mds.26424. Professionals From the American Heart Association/American Stroke Pringsheim T, Okun MS, Miiller-Vahl K, et al. Practice guideline reeommenda- Association. Stroke. 2017:48:e343-e361. [PMID: 29097489] doi:10.1161/ tions summary: treatment of tics in people with Tourette syndrome and STR.0000000000000152 chronic tic disorders. Neurology. 2019 May 7;92(19):896-906. [PMID: Cognitive Impairment 31061208] doi: 10.1212/WNL.0000000000007466. Corbett A, Smith J, Creese B, et al. Treatment of behavioral and psychological Rajan S, Kaas B, Moukheiber E. Movement disorders emergencies. Semin symptoms of Alzheimer’s disease. Curr Treat Options Neurol. 2012 Apr; Neurol. 2019 Feb;39(1):125-36. [PMID: 30743298] doi: 10.1055/s-0038-1677050. 14(2):113-25. [PMID: 22328204] doi:10.1007/s11940-012-0166-9. Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmo- Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion tor symptoms of Parkinson’s disease—an evidence-based medicine review. assessment method. A new method for detection of delirium. Ann Intern Med. Moy Disord. 2019 Feb;34(2):180-98. [PMID: 30653247] doi: 10.1002/ 1990 Dec 15;113(12):941-8. [PMID: 2240918] doi: 10.7326/0003-4819-113-12-941. mds.27602.

narrativemksap-19· p.104

Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion tor symptoms of Parkinson’s disease—an evidence-based medicine review. assessment method. A new method for detection of delirium. Ann Intern Med. Moy Disord. 2019 Feb;34(2):180-98. [PMID: 30653247] doi: 10.1002/ 1990 Dec 15;113(12):941-8. [PMID: 2240918] doi: 10.7326/0003-4819-113-12-941. mds.27602. Lin J, O'Connor E, Rossom R, et al. Screening for cognitive impairment in older Winkelmann J, Allen RP, Hégl B, et al. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Nov 5;159:601-12. [PMID: 24145578]. doi:10.7326/0003- 2017)S. Mov Disord. 2018;33:1077-1091. [PMID: 29756335] doi:10.1002/ 4819-159-9-201311050-00730. mds.27260

narrativemksap-19· p.104

Lin J, O'Connor E, Rossom R, et al. Screening for cognitive impairment in older Winkelmann J, Allen RP, Hégl B, et al. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Nov 5;159:601-12. [PMID: 24145578]. doi:10.7326/0003- 2017)S. Mov Disord. 2018;33:1077-1091. [PMID: 29756335] doi:10.1002/ 4819-159-9-201311050-00730. mds.27260 Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, interven- Multiple Sclerosis tion, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413- Brown J, Coles A, Horakova D, et al. Association of initial disease-modifying ther- 446. [PMID: 32738937] doi:10.1016/S0140-6736(20)30367-6 apy with later conversion to secondary progressive multiple sclerosis. JAMA. McKeith, I, Boeve, B, Dickson D, et al. Diagnosis and management of dementia 2019 Jan 15;321(2):175-87. [PMID: 30644981] doi: 10.1001 /jama.2018.20588. with Lewy bodies: fourth consensus report of the DLB Consortium. Farez MF, Correale J, Armstrong MJ, et al. Practice guideline update summary: Neurology. 2017 Jul 4;89(1):88-100. [PMID: 28592453] doi: 10.1212/WNL. Vaccine-preventable infections and immunization in multiple sclerosis: 0000000000004058. Report of the Guideline Development, Dissemination, and Implementation Mead S, Rudge P. CJD mimics and chameleons. Pract Neurol. 2017:17:113-121. Subcommittee of the American Academy of Neurology. Neurology. [PMID: 28153848] doi:10.1136/practneurol-2016-001571 2019;93:584-594. [PMID: 31462584] doi:10.1212/WNL.0000000000008157 92

narrativemksap-19· p.105

Bibliography Haselkorn J, Hughes C, Rae-Grant A, et al. Summary of comprehensive sys- Wingerchuk D, Banwell B, Bennett J, et al; International Panel for NMO tematic review: rehabilitation in multiple sclerosis: report of the Guideline Diagnosis. International consensus diagnostic criteria for neuromyelitis Development, Dissemination, and Implementation Subcommittee of the optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89. [PMID: American Academy of Neurology. Neurology. 2015 Nov 24;85(21):1896-903. 26092914] doi: 10.1212/WNL.0000000000001729. [PMID: 26598432] doi:10.1212/ WNL.0000000000002146. Wolffenbuttel B, Wouters H, Heiner-Fokkema M, et al. The many faces of Jagannath VA, Filippini G, Di Pietrantonj C, et al. Vitamin D for the manage- cobalamin (vitamin B,,) deficiency. Mayo Clin Proc Innov Qual Outcomes. ment of multiple sclerosis. Cochrane Database Syst Rev. 2018 Sep 24:9: 2019 May 27;3(2):200-14. [PMID: 31193945] doi: 10.1016/j.mayocpiqo. CD008422. [PMID: 30246874] doi: 10.1002/14651858.CD008422.pub3. 2019.03.002.

narrativemksap-19· p.105

Haselkorn J, Hughes C, Rae-Grant A, et al. Summary of comprehensive sys- Wingerchuk D, Banwell B, Bennett J, et al; International Panel for NMO tematic review: rehabilitation in multiple sclerosis: report of the Guideline Diagnosis. International consensus diagnostic criteria for neuromyelitis Development, Dissemination, and Implementation Subcommittee of the optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89. [PMID: American Academy of Neurology. Neurology. 2015 Nov 24;85(21):1896-903. 26092914] doi: 10.1212/WNL.0000000000001729. [PMID: 26598432] doi:10.1212/ WNL.0000000000002146. Wolffenbuttel B, Wouters H, Heiner-Fokkema M, et al. The many faces of Jagannath VA, Filippini G, Di Pietrantonj C, et al. Vitamin D for the manage- cobalamin (vitamin B,,) deficiency. Mayo Clin Proc Innov Qual Outcomes. ment of multiple sclerosis. Cochrane Database Syst Rev. 2018 Sep 24:9: 2019 May 27;3(2):200-14. [PMID: 31193945] doi: 10.1016/j.mayocpiqo. CD008422. [PMID: 30246874] doi: 10.1002/14651858.CD008422.pub3. 2019.03.002. Kingwell E, Leray E, Zhu EF, et al. Multiple sclerosis: effect of beta interferon Neuromuscular Disorders treatment on survival. Brain. 2019 May 1;142(S):1324-33. [PMID: 30883636] doi: 10.1093/brain/awz055. Barohn R, Amato A. Pattern-recognition approach to neuropathy and neu- ronopathy. Neurol Clin. 2013 May;31(2):343-61. [PMID: 23642713] Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multi- doi:10.1016/j.ncl.2013.02.001. ple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15;83(3):278-86. [PMID: 24871874] doi:10.1212/WNL.0000000000000560. Brown R, Al-Chalabi A. Amyotrophic lateral sclerosis. N EnglJ Med. 2017 Jul 13:377(2):162-72. [PMID: 28700839] doi: 10.1056/NEJMral1603471. Minden S, Feinstein A, Kalb R, et al; Guideline Development Subcommittee of the American Academy of Neurology. Evidence-based guideline: assess- Bunschoten C, Jacobs B, Van den Bergh P, et al. Progress in diagnosis and treat- ment and management of psychiatric disorders in individuals with MS: ment of chronic inflammatory demyelinating polyradiculoneuropathy. report of the Guideline Development Subcommittee of the American Lancet Neurol. 2019 Aug;18(8):784-94. [PMID: 31076244] doi:10.1016/ Academy of Neurology. Neurology. 2014 Jan 14;82(2):174-81. [PMID: $1474-4422(19)30144-9. 24376275] doi:10.1212/WNL.0000000000000013. Doughty C, Bowley M. Entrapment neuropathies of the upper extremity. Med Rae-Grant A, Day G, Marrie R, et al. Practice guideline recommendations sum- Clin North Am. 2019 Mar;103(2):357-70. [PMID: 30704687] doi: 10.1016/j. mary: disease-modifying therapies for adults with multiple sclerosis: mena.2018.10.012.

narrativemksap-19· p.105

Kingwell E, Leray E, Zhu EF, et al. Multiple sclerosis: effect of beta interferon Neuromuscular Disorders treatment on survival. Brain. 2019 May 1;142(S):1324-33. [PMID: 30883636] doi: 10.1093/brain/awz055. Barohn R, Amato A. Pattern-recognition approach to neuropathy and neu- ronopathy. Neurol Clin. 2013 May;31(2):343-61. [PMID: 23642713] Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multi- doi:10.1016/j.ncl.2013.02.001. ple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15;83(3):278-86. [PMID: 24871874] doi:10.1212/WNL.0000000000000560. Brown R, Al-Chalabi A. Amyotrophic lateral sclerosis. N EnglJ Med. 2017 Jul 13:377(2):162-72. [PMID: 28700839] doi: 10.1056/NEJMral1603471. Minden S, Feinstein A, Kalb R, et al; Guideline Development Subcommittee of the American Academy of Neurology. Evidence-based guideline: assess- Bunschoten C, Jacobs B, Van den Bergh P, et al. Progress in diagnosis and treat- ment and management of psychiatric disorders in individuals with MS: ment of chronic inflammatory demyelinating polyradiculoneuropathy. report of the Guideline Development Subcommittee of the American Lancet Neurol. 2019 Aug;18(8):784-94. [PMID: 31076244] doi:10.1016/ Academy of Neurology. Neurology. 2014 Jan 14;82(2):174-81. [PMID: $1474-4422(19)30144-9. 24376275] doi:10.1212/WNL.0000000000000013. Doughty C, Bowley M. Entrapment neuropathies of the upper extremity. Med Rae-Grant A, Day G, Marrie R, et al. Practice guideline recommendations sum- Clin North Am. 2019 Mar;103(2):357-70. [PMID: 30704687] doi: 10.1016/j. mary: disease-modifying therapies for adults with multiple sclerosis: mena.2018.10.012. report of the Guideline Development, Dissemination, and Implementation Edmundson C, Bird SJ. Acute Manifestations of Neuromuscular Disease. Semin Subcommittee of the American Academy of Neurology. Neurology. 2018 Apr Neurol. 2019;39:115-124. [PMID: 30743297] doi:10.1055/s-0038-1676838 24; 90(17);777-88. [PMID: 29686116] doi: 10.1212/ WNL.0000000000005347. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: Dis Primers. 2019;5:41. [PMID: 31197153] doi:10.1038/s41572-019-0092-1 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-173. Narayanaswami P, Sanders DB, Wolfe G, et al. International Consensus [PMID: 29275977] doi:10.1016/S1474-4422(17)30470-2 Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. Traboulsee A, Simon JH, Stone L, et al. Revised Recommendations of the 2021;96:114-122. [PMID: 33144515] doi:10.1212/ WNL.0000000000011124 Consortium of MS Centers Task Force for a Standardized MRI Protocol and Hilton-Jones D. Statin-related myopathies. Pract Neurol. 2018 Apr;18(2):97- Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. 105. [PMID: 29496886] doi: 10.1136/practneurol-2017-001738. AJNR Am J Neuroradiol. 2016;37:394-401. [PMID: 26564433] doi:10.3174/ ajnr.A4539 Novak P. Autonomic disorders. Am J Med. 2019 Apr;132(4):420-36. [PMID: 30308186] doi: 10.1016/j.amjmed.2018.09.027. Yadav V, Bever C Jr, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of Willison H, Jacobs B, van Doorn P. Guillain-Barré syndrome. Lancet. 2016 Aug the guideline development subcommittee of the American Academy of 13;388(10045):717-27. [PMID: 26948435] doi: 10.1016/S0140-6736(16)00339-1. Neurology. Neurology. 2014 Mar 25;82(12):1083-92. [PMID: 24663230] doi:10.1212/WNL.0000000000000250. Neuro-oncology

narrativemksap-19· p.105

report of the Guideline Development, Dissemination, and Implementation Edmundson C, Bird SJ. Acute Manifestations of Neuromuscular Disease. Semin Subcommittee of the American Academy of Neurology. Neurology. 2018 Apr Neurol. 2019;39:115-124. [PMID: 30743297] doi:10.1055/s-0038-1676838 24; 90(17);777-88. [PMID: 29686116] doi: 10.1212/ WNL.0000000000005347. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: Dis Primers. 2019;5:41. [PMID: 31197153] doi:10.1038/s41572-019-0092-1 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-173. Narayanaswami P, Sanders DB, Wolfe G, et al. International Consensus [PMID: 29275977] doi:10.1016/S1474-4422(17)30470-2 Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. Traboulsee A, Simon JH, Stone L, et al. Revised Recommendations of the 2021;96:114-122. [PMID: 33144515] doi:10.1212/ WNL.0000000000011124 Consortium of MS Centers Task Force for a Standardized MRI Protocol and Hilton-Jones D. Statin-related myopathies. Pract Neurol. 2018 Apr;18(2):97- Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. 105. [PMID: 29496886] doi: 10.1136/practneurol-2017-001738. AJNR Am J Neuroradiol. 2016;37:394-401. [PMID: 26564433] doi:10.3174/ ajnr.A4539 Novak P. Autonomic disorders. Am J Med. 2019 Apr;132(4):420-36. [PMID: 30308186] doi: 10.1016/j.amjmed.2018.09.027. Yadav V, Bever C Jr, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of Willison H, Jacobs B, van Doorn P. Guillain-Barré syndrome. Lancet. 2016 Aug the guideline development subcommittee of the American Academy of 13;388(10045):717-27. [PMID: 26948435] doi: 10.1016/S0140-6736(16)00339-1. Neurology. Neurology. 2014 Mar 25;82(12):1083-92. [PMID: 24663230] doi:10.1212/WNL.0000000000000250. Neuro-oncology Englot DJ, Magill ST, Han SJ, et al. Seizures in supratentorial meningioma: a Disorders of the Spinal Cord systematic review and meta-analysis. J Neurosurg. 2016;124:1552-61. Babu JM, Patel SA, Palumbo MA, et al. Spinal emergencies in primary care [PMID: 26636386] doi:10.3171/2015.4.JNS142742 practice. AmJ Med. 2019 Mar;132(3):300-6. [PMID: 30291829] doi: 10.1016/j. Han CH, Batchelor TT. Primary central nervous system lymphoma. amjmed.2018.09.022. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1601-18. George R, Jeba J, Ramkumar G, et al. Interventions for the treatment of meta- Hoang-Xuan K, Bessell E, Bromberg J, et al; European Association for Neuro- static extradural spinal cord compression in adults. Cochrane Database Syst Oncology Task Force on Primary CNS Lymphoma. Diagnosis and treatment Rev. 2015 Sep 4;(9):CD006716. [PMID: 26337716] doi: 10.1002/14651858. of primary CNS lymphoma in immunocompetent patients: guidelines from CD006716.pub3. the European Association for Neuro-Oncology. Lancet Oncol. 2015 Ropper AE, Ropper AH. Acute spinal cord compression. N Engl J Med. 2017 Apr Jul;16(7):e322-32. [PMID: 26149884] doi:10.1016/S1470-2045(15)00076-5. 6;376(14):1358-69. [PMID: 28379788] DOI: 10.1056/NEJMra1516539. Lancaster E. Paraneoplastic disorders. CONTINUUM: Lifelong Learning in Scott TF, Frohman EM, De Seze J, et al; Therapeutics and Technology Neurology. 2017 Dec 1;23(6):1653-79. Assessment Subcommittee of American Academy of Neurology. Evidence- McKeon A. Autoimmune encephalopathies and dementias. Continuum based guideline: clinical evaluation and treatment of transverse myelitis: (Minneap Minn). 2016 Apr;22(2 Dementia):538-58. [PMID: 27042907] doi: report of the Therapeutics and Technology Assessment Subcommittee of 10.1212/CON.0000000000000299. the American Academy of Neurology. Neurology. 2011;77:2128-34. [PMID: 22156988] doi:10.1212/ WNL.0b013e31823dc535 Mohile NA. Medical complications of brain tumors. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1635-52. Sechi E, Shosha E, Williams JP, et al. Aquaporin-4 and MOG autoantibody dis- covery in idiopathic transverse myelitis epidemiology. Neurology. 2019;93: Strowd III RE, Blakeley JO. Common histologically benign tumors of the brain. e414-e420. [PMID: 31235660] doi:10.1212/WNL.0000000000007828 CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1680-708.

narrativemksap-19· p.105

Englot DJ, Magill ST, Han SJ, et al. Seizures in supratentorial meningioma: a Disorders of the Spinal Cord systematic review and meta-analysis. J Neurosurg. 2016;124:1552-61. Babu JM, Patel SA, Palumbo MA, et al. Spinal emergencies in primary care [PMID: 26636386] doi:10.3171/2015.4.JNS142742 practice. AmJ Med. 2019 Mar;132(3):300-6. [PMID: 30291829] doi: 10.1016/j. Han CH, Batchelor TT. Primary central nervous system lymphoma. amjmed.2018.09.022. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1601-18. George R, Jeba J, Ramkumar G, et al. Interventions for the treatment of meta- Hoang-Xuan K, Bessell E, Bromberg J, et al; European Association for Neuro- static extradural spinal cord compression in adults. Cochrane Database Syst Oncology Task Force on Primary CNS Lymphoma. Diagnosis and treatment Rev. 2015 Sep 4;(9):CD006716. [PMID: 26337716] doi: 10.1002/14651858. of primary CNS lymphoma in immunocompetent patients: guidelines from CD006716.pub3. the European Association for Neuro-Oncology. Lancet Oncol. 2015 Ropper AE, Ropper AH. Acute spinal cord compression. N Engl J Med. 2017 Apr Jul;16(7):e322-32. [PMID: 26149884] doi:10.1016/S1470-2045(15)00076-5. 6;376(14):1358-69. [PMID: 28379788] DOI: 10.1056/NEJMra1516539. Lancaster E. Paraneoplastic disorders. CONTINUUM: Lifelong Learning in Scott TF, Frohman EM, De Seze J, et al; Therapeutics and Technology Neurology. 2017 Dec 1;23(6):1653-79. Assessment Subcommittee of American Academy of Neurology. Evidence- McKeon A. Autoimmune encephalopathies and dementias. Continuum based guideline: clinical evaluation and treatment of transverse myelitis: (Minneap Minn). 2016 Apr;22(2 Dementia):538-58. [PMID: 27042907] doi: report of the Therapeutics and Technology Assessment Subcommittee of 10.1212/CON.0000000000000299. the American Academy of Neurology. Neurology. 2011;77:2128-34. [PMID: 22156988] doi:10.1212/ WNL.0b013e31823dc535 Mohile NA. Medical complications of brain tumors. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1635-52. Sechi E, Shosha E, Williams JP, et al. Aquaporin-4 and MOG autoantibody dis- covery in idiopathic transverse myelitis epidemiology. Neurology. 2019;93: Strowd III RE, Blakeley JO. Common histologically benign tumors of the brain. e414-e420. [PMID: 31235660] doi:10.1212/WNL.0000000000007828 CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1680-708. 93